Shanghai Ambrosia Pharmaceuticals Co., Ltd. is a privately owned biopharmaceutical company dedicated to the discovery and development of novel therapeutics and health products for the treatment of immune diseases and cancer. The Shanghai Ambrosia was established in 2002 at the Pudong Zhangjiang High-Tech Park by a group of world-renowned scientists from Harvard University, Johns Hopkins University, Indiana University and Boston University, experts of pharmaceuticals in America, as well as scientists from the Chinese Academy of Sciences and Tsinghua University